These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 28771728)

  • 1. Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer.
    Sethia R; Yumusakhuylu AC; Ozbay I; Diavolitsis V; Brown NV; Zhao S; Wei L; Old M; Agrawal A; Teknos TN; Ozer E
    Laryngoscope; 2018 Feb; 128(2):403-411. PubMed ID: 28771728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
    Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transoral robotic surgery for oropharyngeal cancer: long-term quality of life and functional outcomes.
    Dziegielewski PT; Teknos TN; Durmus K; Old M; Agrawal A; Kakarala K; Marcinow A; Ozer E
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1099-108. PubMed ID: 23576186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
    Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
    Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
    Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
    Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma.
    Sinclair CF; McColloch NL; Carroll WR; Rosenthal EL; Desmond RA; Magnuson JS
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1112-6. PubMed ID: 22106235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and functional evaluation in patients with tongue base tumors treated exclusively with transoral robotic surgery: A 1-year follow-up study.
    Mercante G; Masiello A; Sperduti I; Cristalli G; Pellini R; Spriano G
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1561-6. PubMed ID: 26197796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
    Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
    Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
    Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer.
    Sher DJ; Fidler MJ; Tishler RB; Stenson K; al-Khudari S
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):512-22. PubMed ID: 26867880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience.
    Meccariello G; Bianchi G; Calpona S; Parisi E; Cammaroto G; Iannella G; Sgarzani R; Montevecchi F; De Vito A; Capaccio P; Pelucchi S; Vicini C
    Oral Oncol; 2020 Nov; 110():104889. PubMed ID: 32653838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?
    Gallitto M; Sindhu K; Wasserman I; De B; Gupta V; Miles BA; Genden EM; Posner M; Misiukiewicz K; Bakst RL
    Head Neck; 2019 Sep; 41(9):3009-3022. PubMed ID: 30997703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.